{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:01:06Z","timestamp":1781049666057,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001427","name":"All India Council for Technical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001427","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jsbmb.2026.107026","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:11:00Z","timestamp":1776726660000},"page":"107026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel 5\u03b1-reductase inhibitors unlinked to depression-like phenotypes in rat model of BPH"],"prefix":"10.1016","volume":"262","author":[{"given":"Bhawna","family":"Khanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta Pilkhwal","family":"Sah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelima","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2026.107026_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11934-022-01091-z","article-title":"Surgical complications in the management of benign prostatic hyperplasia treatment","volume":"23","author":"Ottaiano","year":"2022","journal-title":"Curr. Urol. Rep."},{"key":"10.1016\/j.jsbmb.2026.107026_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.554078","article-title":"Endocrinology of the aging prostate: current concepts","volume":"12","author":"Cannarella","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.jsbmb.2026.107026_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ajur.2017.06.004","article-title":"Epidemiology of clinical benign prostatic hyperplasia","volume":"4","author":"Lim","year":"2017","journal-title":"Asian J. Urol."},{"key":"10.1016\/j.jsbmb.2026.107026_bib4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000496289","article-title":"Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement: a mini-review","volume":"65","author":"Madersbacher","year":"2019","journal-title":"Gerontology"},{"key":"10.1016\/j.jsbmb.2026.107026_bib5","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1016\/S2666-7568(22)00213-6","article-title":"The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"3","author":"Awedew","year":"2022","journal-title":"Lancet Heal. Longev."},{"key":"10.1016\/j.jsbmb.2026.107026_bib6","first-page":"301","article-title":"Lower urinary tract symptoms, benign prostatic hyperplasia, and urinary retention","volume":"102","author":"Alawamlh","year":"2018","journal-title":"Med. Clin."},{"key":"10.1016\/j.jsbmb.2026.107026_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0090-4295(03)00045-1","article-title":"The role of dihydrotestosterone in benign prostatic hyperplasia","volume":"61","author":"Carson III","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.jsbmb.2026.107026_bib8","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/01.ju.0000139539.94828.29","article-title":"Dihydrotestosterone and the prostate: the scientific rationale for 5\u03b1-reductase inhibitors in the treatment of benign prostatic hyperplasia","volume":"172","author":"Andriole","year":"2004","journal-title":"J. Urol."},{"key":"10.1016\/j.jsbmb.2026.107026_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0165-0173(01)00109-6","article-title":"Biosynthesis and action of neurosteroids","volume":"37","author":"Mellon","year":"2001","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.jsbmb.2026.107026_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.yfrne.2009.05.006","article-title":"Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides","volume":"30","author":"Do Rego","year":"2009","journal-title":"Front. Neuroendocr."},{"key":"10.1016\/j.jsbmb.2026.107026_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jsbmb.2017.04.003","article-title":"Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients","volume":"171","author":"Melcangi","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2026.107026_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2019.100209","article-title":"Post-finasteride syndrome: an emerging clinical problem","volume":"12","author":"Diviccaro","year":"2020","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.jsbmb.2026.107026_bib13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4103\/aja202171","article-title":"Sexual, physical, and overall adverse effects in patients treated with 5\u03b1-reductase inhibitors: a systematic review and meta-analysis","volume":"24","author":"Zhang","year":"2022","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.jsbmb.2026.107026_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.therap.2025.09.004","article-title":"Isolated depressive disorders and suicidality with finasteride use for androgenetic alopecia: a call for enhanced vigilance","author":"Geniaux","year":"2025","journal-title":"Therapies"},{"key":"10.1016\/j.jsbmb.2026.107026_bib15","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/ph18070957","article-title":"Suicidality risks associated with finasteride, a 5-alpha reductase inhibitor: an evaluation of real-world data from the FDA adverse event reports","volume":"18","author":"Thaibah","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jsbmb.2026.107026_bib16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1346-8138.2002.tb00200.x","article-title":"Depression circumstantially related to the administration of finasteride for androgenetic alopecia","volume":"29","author":"Altomare","year":"2002","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jsbmb.2026.107026_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l5047","article-title":"Post-finasteride syndrome","author":"Gray","year":"2019","journal-title":"BMj 366"},{"key":"10.1016\/j.jsbmb.2026.107026_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/1557988314538445","article-title":"Persistent sexual, emotional, and cognitive impairment post-finasteride: a survey of men reporting symptoms","volume":"9","author":"Ganzer","year":"2015","journal-title":"Am. J. Mens. Health"},{"key":"10.1016\/j.jsbmb.2026.107026_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.euros.2023.04.009","article-title":"US Food and Drug Administration warning regarding finasteride and suicidal ideation: what should urologists know?","volume":"52","author":"Al Saffar","year":"2023","journal-title":"Eur. Urol. Open Sci."},{"key":"10.1016\/j.jsbmb.2026.107026_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2025.2574304","article-title":"Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study","volume":"36","author":"Hu","year":"2025","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.jsbmb.2026.107026_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1434961","article-title":"Recent approaches of antibody therapeutics in androgenetic alopecia","volume":"15","author":"Jin","year":"2024","journal-title":"Front. Pharm."},{"key":"10.1016\/j.jsbmb.2026.107026_bib22","article-title":"Prescription trends of initial pharmacotherapy for benign prostatic hyperplasia among treatment-na\u00efve patients in South Korea: a retrospective analysis","volume":"17","author":"Kim","year":"2025","journal-title":"LUTS Low. Urin. Trac. Symptoms"},{"key":"10.1016\/j.jsbmb.2026.107026_bib23","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3109\/14756366.2012.729827","article-title":"In vivo and in vitro effect of androstene derivatives as 5\u03b1-reductase type 1 enzyme inhibitors","volume":"28","author":"Bratoeff","year":"2013","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.jsbmb.2026.107026_bib24","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1021\/jm001008m","article-title":"Synthesis and evaluation of novel steroidal oxime inhibitors of P450 17 (17\u03b1-hydroxylase\/C17\u2212 20-lyase) and 5\u03b1-reductase types 1 and 2","volume":"43","author":"Hartmann","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2026.107026_bib25","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.ejmech.2010.01.064","article-title":"Synthesis, antiproliferative, acute toxicity and assessment of antiandrogenic activities of some newly synthesized steroidal lactams","volume":"45","author":"Dhingra","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2026.107026_bib26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s12272-011-0702-2","article-title":"Synthesis, antiproliferative activity, acute toxicity and assessment of the antiandrogenic activities of new androstane derivatives","volume":"34","author":"Dhingra","year":"2011","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jsbmb.2026.107026_bib27","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00044-010-9393-3","article-title":"17-Oximino-5-androsten-3\u03b2-yl esters: synthesis, antiproliferative activity, acute toxicity, and effect on serum androgen level","volume":"20","author":"Dhingra","year":"2011","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jsbmb.2026.107026_bib28","doi-asserted-by":"crossref","unstructured":"W.Y. Wang YuRong, X.Y. Xu Yuan, J.Z. Jiang ZhenZhou, Z.L. Zhang LuYong, W.T. Wang Tao, Triptolide reduces prostate size and androgen level on testosterone-induced benign prostatic hyperplasia in Sprague Dawley rats., (2017).","DOI":"10.1016\/S1875-5364(17)30054-7"},{"key":"10.1016\/j.jsbmb.2026.107026_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173631","article-title":"Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: the role of VEGF\/TGF\u03b2 and iNOS\/COX-2","volume":"889","author":"Abdel-Aziz","year":"2020","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.jsbmb.2026.107026_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121747","article-title":"Comparative effects of finasteride and laser-irradiated silver nanoparticles on testicular function and histology in testosterone induced benign prostatic hyperplasia in rats","volume":"324","author":"Marghani","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.jsbmb.2026.107026_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5214\/ans.0972.7531.1118204","article-title":"Study of CNS depressant and behavioral activity of an ethanol extract of Achyranthes aspera (Chirchita) in mouse model","volume":"18","author":"Bhosale","year":"2011","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.jsbmb.2026.107026_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbr.2019.03.006","article-title":"Repeated finasteride administration induces depression-like behavior in adult male rats","volume":"365","author":"Sasibhushana","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jsbmb.2026.107026_bib33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.jsbmb.2026.107026_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6904-6-7","article-title":"Finasteride induced depression: a prospective study","volume":"6","author":"Rahimi-Ardabili","year":"2006","journal-title":"BMC Clin. Pharm."},{"key":"10.1016\/j.jsbmb.2026.107026_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4111\/kju.2014.55.6.367","article-title":"The dark side of 5\u03b1-reductase inhibitors\u2019 therapy: sexual dysfunction, high gleason grade prostate cancer and depression","volume":"55","author":"Traish","year":"2014","journal-title":"Korean J. Urol."},{"key":"10.1016\/j.jsbmb.2026.107026_bib36","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1248\/bpb.31.1646","article-title":"Studies on Neurosteroids XXV. Influence of a 5\u03b1-Reductase Inhibitor, Finasteride, on Rat Brain Neurosteroid Levels and Metabolism","volume":"31","author":"Mukai","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jsbmb.2026.107026_bib37","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00213-005-0148-7","article-title":"Pharmacokinetic and behavioral effects of allopregnanolone in healthy women","volume":"186","author":"Timby","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jsbmb.2026.107026_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pneurobio.2013.09.003","article-title":"The role of allopregnanolone in depression and anxiety","volume":"113","author":"Sch\u00fcle","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jsbmb.2026.107026_bib39","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.psyneuen.2009.08.009","article-title":"Neurosteroids: endogenous allosteric modulators of GABAA receptors","volume":"34","author":"Lambert","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jsbmb.2026.107026_bib40","article-title":"Factors associated with quality of life in patients with benign prostatic hyperplasia, 2009\u20132016","volume":"101","author":"Park","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.jsbmb.2026.107026_bib41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000358838","article-title":"Low serum allopregnanolone is associated with symptoms of depression in late pregnancy","volume":"69","author":"Hellgren","year":"2014","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jsbmb.2026.107026_bib42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2826.1995.tb00744.x","article-title":"Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors","volume":"7","author":"Bitran","year":"1995","journal-title":"J. Neuroendocr."},{"key":"10.1016\/j.jsbmb.2026.107026_bib43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0091-3057(00)00300-2","article-title":"Antidepressant-like effect of the neurosteroid 3\u03b1-hydroxy-5\u03b1-pregnan-20-one in mice forced swim test","volume":"67","author":"Khisti","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jsbmb.2026.107026_bib44","article-title":"Corrigendum: allopregnanolone, the neuromodulator turned therapeutic agent: thank you, next?","volume":"11","author":"Pinna","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.jsbmb.2026.107026_bib45","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbr.2009.09.028","article-title":"Infusions of anti-sense oligonucleotides for DARPP-32 to the ventral tegmental area reduce effects of progesterone-and a dopamine type 1-like receptor agonist to facilitate lordosis","volume":"206","author":"Frye","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jsbmb.2026.107026_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.pharmtox.44.101802.121415","article-title":"DARPP-32: an integrator of neurotransmission","volume":"44","author":"Svenningsson","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jsbmb.2026.107026_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/cns.12781","article-title":"Finasteride inhibited brain dopaminergic system and open-field behaviors in adolescent male rats","volume":"24","author":"Li","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jsbmb.2026.107026_bib48","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1159\/000442982","article-title":"Effects of subchronic finasteride treatment and withdrawal on neuroactive steroid levels and their receptors in the male rat brain","volume":"103","author":"Giatti","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jsbmb.2026.107026_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112100","article-title":"The connection of 5-alpha reductase inhibitors to the development of depression","volume":"143","author":"Saengmearnuparp","year":"2021","journal-title":"Biomed. Pharm."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076026000920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076026000920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:33:41Z","timestamp":1781048021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076026000920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":49,"alternative-id":["S0960076026000920"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2026.107026","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel 5\u03b1-reductase inhibitors unlinked to depression-like phenotypes in rat model of BPH","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2026.107026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107026"}}